Physical and Chemical Responses in Animals

Q1 — Sample Band 6 response (8 marks), annotated

Burns exceeding 30% TBSA destroy the keratinised epidermis over a vast surface area, eliminating the body's primary physical barrier to pathogen entry. The skin normally acts as a tough, multilayered, slightly acidic barrier that constantly sheds dead outer cells (removing surface microbes) and inhibits bacterial growth through its pH. Loss of this barrier — combined with the loss of sebaceous gland secretions (sebum) and the disruption of the normal skin microbiome — removes every component of external physical defence simultaneously, leaving subcutaneous tissue directly exposed to environmental pathogens. This explains the dramatic increase from 12% to 78% infection rate as TBSA involvement increases. [1 — specific physical barriers lost: keratinised epidermis, sebum, skin microbiome]

The elevated IL-6 and TNF-α at days 3–5 are key pro-inflammatory cytokines released by macrophages at the wound site. IL-6 and TNF-α travel via the bloodstream to the hypothalamus, where they act as pyrogens — triggering the hypothalamus to raise its temperature set point. This produces the characteristic systemic fever (vasoconstriction and shivering increase core body temperature to the new set point). The observed fever of 38.5–39.2°C is therefore a direct consequence of the cytokine storm from active macrophage response to burn-site bacterial contamination. [1 — cytokines → hypothalamus → fever mechanism]

Comparing the two strategies on three outcome measures: (1) Confirmed infection rate was nearly identical — 41% (Strategy A) vs 39% (Strategy B) — meaning broad-spectrum antibiotics from day 1 provided no significant reduction in infection incidence, while exposing patients to the resistance risk of unnecessary antibiotic use. (2) Ciprofloxacin-resistant E. coli isolates were 58% in Strategy A vs 17% in Strategy B — a striking three-fold increase in resistance in patients receiving prophylactic antibiotics. (3) Mean hospital stay was 28.4 vs 24.8 days — Strategy B patients had shorter stays, possibly because their innate immune response (including the permitted fever) was not suppressed. [1 — three outcomes compared with data values]

Strategy A's use of broad-spectrum antibiotics from day 1 carries a significant resistance trade-off. The lesson notes that the physical barrier is always the most important defence, and that antibiotics do not restore or replace it. The 58% ciprofloxacin-resistant isolate rate in Strategy A patients means that when infections do occur in these patients, they may be harder to treat — a clinical outcome worse than the original risk. This is an iatrogenic harm introduced by overly aggressive antibiotic use. [1 — trade-off of Strategy A: resistance data + lesson context]

The lesson explicitly states that "a mild fever (37–38.5°C) may be best left to run its course." Strategy B's mean peak fever of 38.7°C is within or just above this range, while Strategy A's suppressed 37.9°C mean falls below the lesson's data-supported peak phagocytosis range (38.0–38.5°C). By permitting moderate fever in Strategy B, clinicians allowed the innate immune response to operate at closer to its thermal optimum. The data from Worksheet 2's dataset (from the lesson) confirm that neutrophil phagocytosis is highest around 38.0–38.5°C; Strategy B's mean fever sits within this range. [1 — lesson's fever position applied to Strategy B data]

The mortality data (14% vs 11%) and hospital stay data both favour Strategy B, despite similar initial infection rates. This suggests that permitting the innate immune system to operate — including moderate fever — while reserving antibiotics for confirmed infections produces better clinical outcomes. The innate immune response (including the cytokine-driven fever) is doing meaningful work even in the absence of an intact physical barrier. [1 — integrated use of data: mortality + hospital stay + immune rationale]

My recommendation is Strategy B: targeted antibiotic therapy plus active fever monitoring with the threshold for suppression set at 39.0°C. The physical barrier has been lost, so wound management (debridement, dressings that partially restore the barrier function) must substitute for what burns have destroyed. The chemical response — cytokines, fever, complement, and neutrophil recruitment — should be supported rather than suppressed below the 39°C danger threshold. Broad-spectrum prophylactic antibiotics should be avoided unless cultures confirm an infection, given the 3-fold increase in resistant isolates they produce. [1 — justified recommendation integrating physical defence, chemical physiology, and evidence]

Marking criteria (8 marks):

• 1 mark — Correctly identifies the specific physical barriers lost in severe burns (keratinised epidermis, sebum, skin microbiome) and links this to the high infection rate.
• 1 mark — Identifies IL-6 and TNF-α as cytokines produced by macrophages and correctly traces the pathway from cytokine release → hypothalamus → raised temperature set point → fever.
• 1 mark — Compares the two strategies on at least three specific outcome measures, quoting data values from the table.
• 1 mark — Evaluates Strategy A's resistance trade-off using the ciprofloxacin-resistant isolate data (58% vs 17%) and connects this to the lesson's physical-barrier-first principle.
• 1 mark — Applies the lesson's fever management position (moderate fever supports immune function; suppress only above ~39–40°C) to distinguish the two strategies' fever profiles.
• 1 mark — Integrates mortality and hospital-stay data to support a conclusion about which strategy is superior and why (immune function preserved + less resistance).
• 1 mark — Reaches a specific, justified recommendation with wound management included (not just "use Strategy B"), integrating physical and chemical response physiology.
• 1 mark — Uses precise lesson terminology throughout (keratinised epidermis, cytokines, pyrogen, hypothalamus, phagocytosis, innate immune response, complement, prostaglandins, or similar).

Q2 — Sample Band 6 response (7 marks), annotated

The guide contains three claims, two of which are substantially incorrect and one that is only partially correct. [1 — overall evaluative judgement]

Claim 1: "Fever is your body overheating and can only make infection worse by speeding up bacterial growth." This is incorrect. Fever is not uncontrolled overheating — it is a deliberate adaptive response coordinated by the hypothalamus, which raises its thermostat set point in response to pyrogens (IL-1, IL-6, TNF-α, prostaglandins) from immune cells. The hypothalamus actively drives the temperature increase via shivering and peripheral vasoconstriction. Furthermore, the claim about fever speeding bacterial growth is the opposite of what is observed: the lesson's data show bacterial replication rate declines with increasing temperature above 37°C (from 2.9 doublings/hr at 37.0°C to 1.5 at 41.5°C). A moderate fever does not help bacteria — it slows them. [1 — refutes "overheating" with hypothalamus mechanism; 1 — refutes "speeds bacterial growth" with data]

Claim 2: "Your immune system works the same at all temperatures." This is incorrect. The lesson's in vitro dataset from the burns worksheet demonstrates clearly that neutrophil phagocytosis rate varies significantly with temperature — peaking at 38.5°C (7.4 bacteria/neutrophil/hr) and falling to 2.9 at 41.5°C and 4.1 at 36.0°C. Immune enzyme reactions, like all biochemical reactions in a non-extremophile organism, are temperature-sensitive within a physiological range. A moderate fever (38.0–38.5°C) enhances rather than impairs innate immune function. [1 — refutes temperature-independence with lesson dataset]

Claim 3: "Always suppress fever as soon as possible." This is partially incorrect. The lesson and clinical evidence support suppressing fever above 40°C (which risks enzyme denaturation, seizures, and organ damage) and in vulnerable populations (infants, immunocompromised, seizure risk). However, the lesson explicitly states that mild fever (37–38.5°C) may be best left to run its course because it is enhancing immune function. Blanket suppression of any fever above 37.5°C would suppress the immune system's own thermal optimisation of phagocytosis. [1 — nuanced evaluation of Claim 3: correct context for suppression vs. overreach]

Experimental test of Claim 2 (the most significant factual error): To test whether the immune system works identically at all temperatures, a researcher could conduct an in vitro experiment: isolate neutrophils from human volunteers, divide into 7 matched groups, expose each to a standardised Staphylococcus aureus suspension at controlled temperatures from 36.0°C to 41.5°C in increments of 0.5°C, and measure phagocytosis rate (bacteria engulfed per neutrophil per hour) after 1 hour using microscopy or fluorescence. A control group (saline, no bacteria) at each temperature would confirm any temperature effect on neutrophil behaviour itself. If the claim were correct, phagocytosis rate would not vary significantly across temperatures. If the lesson's position is correct, a statistically significant peak would be observed around 38–38.5°C with decline at extremes. [1 — experimental design with variables, control, and predicted outcomes]

Marking criteria (7 marks):

• 1 mark — States an overall evaluative judgement (e.g. "The guide contains two substantially incorrect claims and one that is only partially correct").
• 1 mark — Correctly refutes "fever = overheating": fever is a deliberate, regulated response coordinated by the hypothalamus in response to pyrogens from immune cells — the set point is raised, not lost.
• 1 mark — Correctly refutes "fever speeds bacterial growth": lesson data show bacterial replication rate declines with temperature — a moderate fever slows pathogen proliferation.
• 1 mark — Correctly refutes "immune system works the same at all temperatures": neutrophil phagocytosis is temperature-dependent, peaking at ~38.5°C and declining at higher or lower temperatures.
• 1 mark — Correctly nuances Claim 3: some fever suppression is appropriate (above 40°C; infants; seizure risk) but blanket suppression above 37.5°C would impair immune function in the range where phagocytosis is enhanced.
• 1 mark — Proposes a testable experimental design to address the temperature-independence claim, with: independent variable (temperature), dependent variable (phagocytosis rate), controlled variable (bacterial suspension/concentration/neutrophil count), and control condition.
• 1 mark — States predicted results consistent with lesson biology (peak phagocytosis around 38–38.5°C, decline above and below).